VolitionRx Limited announced the creation of a wholly-owned U.S. subsidiary, Volition America Inc., which will be based in Austin, Texas. Dr. Jason Terrell, Chief Medical Officer of Volition, has been appointed as President and Chief Executive Officer of Volition America. Scott Powell, Executive Vice President of Volition, will serve as Vice President and Chief Financial Officer of Volition America. Dr. Terrell will lead the commercialization efforts of the Nu.Q(TM) cancer tests in the United States, focused on
implementing 510(k) and PMA trials for Colorectal Cancer.